Founded in 1993, the Chinese Society of Biotechnology serves as a channel for the exchange of scientific work and thoughts in biotechnology. It promotes scientific collaborations through various academic programs and activities. It bridges academia with enterprises to accelerate the development and commercialization of biotechnology. It also plays an important role in knowledge radiation and enhancement of scientific literacy.

We bring engineers, product developers with scientists and practitioners together to gain valuable information on the latest trends of biochip technologies and their applications in complex systems. BioCHIP Berlin is the forward-looking forum for reporting aatest advances in microfluidics, biofabrication, nanotechnology, integration, materials and surfaces, analysis and synthesis, and detection technologies for the life sciences and chemistry.

China National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large healthcare group directly under the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, with 128,000 employees and a full chain in the industry covering R&D, manufacturing, logistics and distribution, retail chains, healthcare, engineering services, exhibitions and conferences, international business and financial services.

China National Center for Biotechnology Development (abbreviated as CNCBD in the following description) is an organization established on November 3, 1983 under the Ministry of Science and Technology with the approval of the State Council.